OBJECTIVE: Chondroitin sulfate is an acidic polymer consisting of repeating D-glucuronic acid and D-N-acetylgalactosamine units, and the N-acetylgalactosamine is substituted with the sulfate at either the 4 H or 6 H position, with approximately one sulfate being present per disaccharide unit. The present study assessed the effects of chondroitin sulfate on the activity of pancreatic lipase and lipid uptake into brush border membrane vesicles of the rat small intestine in vitro, and on the degree of fat storage induced in mice by the oral administration of a high-fat diet for 8 weeks. DESIGN AND MEASUREMENTS: Experiments were carried out to clarify whether or not chondroitin sulfate inhibited pancreatic lipase activity in assay systems using triolein emulsi®ed with phosphatidylcholine or gum arabic. In addition, the effects of chondroitin sulfate on lipid absorption by brush border membrane vesicles were examined. Moreover, mice were fed a high-fat diet and treated with chondroitin sulfate for 8 weeks. RESULTS: Chondroitin sulfate dose-dependently inhibited the pancreatic lipase activity in an assay system using triolein emulsi®ed with phosphatidylcholine. In addition, chondroitin sulfate inhibited the palmitic acid uptake into the brush border membrane vesicles of the rat jejunum. Chondroitin sulfate caused the reduction of body weight and parametrial adipose tissue weight, and prevention of fatty liver and hyperlipidemia in mice fed a high-fat diet. CONCLUSION: The reduction of fat storage and the antihyperlipidemic action of chondroitin sulfate might be due to the inhibition of small intestinal absorption of dietary fat through the inhibition of pancreatic lipase activity and fatty acid uptake through brush border membrane.
Introduction
Chondroitin sulfate consists of repeating D-glucuronic acid and D-N-acetylgalactosamine units, and the Nacetylgalactosamine is substituted with a sulfate at either its 4 H or 6 H position, with approximately one sulfate being present per disaccharide unit. Chondroitin sulfate is present in the cartilage, bone and cornea of animals. Previously, we reported that chondroitin sulfate prepared from the nasal cartilage of salmon inhibited glucose uptake into brush border membrane vesicles prepared from rat jejunum. 1 In a series of studies on the physiological and pharmacological actions of foods, we have already found that a new phenylglucoside isolated from black sugar, 2 ± 4 a basic protein, protamine, of soft roe, 5 and also chitosan 6 and oolong tea 7 have antiobesity andaor antihyperlpidemia actions mediated through inhibition of the intestinal absorption of dietary carbohydrates and fats. Based on the inhibitory action of chondroitin sulfate on glucose uptake in the small intestine, we studied the effects of chondroitin sulfate on pancreatic lipase activity and fatty acid uptake into brush border membrane vesicles in vitro. In addition, we examined the effects of chondroitin sulfate on plasma triacylglycerol levels after oral administration of lipid emulsion. Moreover, the present investigation was designed to clarify whether or not chondroitin sulfate prevented the obesity induced by longer-term feeding of a highfat diet (8 weeks). [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C] Palmitic acid (2.1 GBqammol) and [9, H] trioleoylglycerol (991.6 GBqammol) were obtained from Du Pont NEN. purchased from Sigma (St. Louis, MO). Lipid assay kits (Triglyceride E-Test Wako, Total Cholesterol ETest Wako and NEFA C-Test Wako) were purchased from Wako Pure Chemical Industries (Osaka, Japan). Laboratory pellet chow was purchased from CLEA Japan (Osaka, Japan). Vitamin and mineral mixtures were obtained from Oriental Yeast Co. Ltd (Tokyo, Japan). Other chemicals were of reagent grade.
Materials and methods

Materials
Animals
Female ICR strain mice (3 weeks old) and male Wistar King strain rats (7 weeks old, 200 ± 220 g body weight) were obtained from CLEA Japan (Osaka, Japan) and Charles River Japan (Yokohama, Japan), respectively, and housed for 1 week in a 12a12 h lightadark cycle in a temperature-and humidity-controlled room. The animals were given free access to food and water. After adaptation to the lighting conditions for 1 week, the healthy animals were used in the present experiments. The experiment protocol was approved by the Animal Studies Committee of Ehime University.
Experimental protocol
Preparation of chondroitin sulfate from salmon nasal cartilage. Salmon nasal cartilage was powdered by freeze drying and exhaustively defatted with petroleum ether. The dry defatted material was extracted with 0.2 N NaOH solution and successively treated with protease as described method by Takeda et al.
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The purity of the obtained chondroitin sulfate was about 95%. The average molecular weight of the chondroitin sulfate used in the present experiment was about 89.8 kDa, which was estimated on the basis of the standard pullulan.
Measurement of pancreatic lipase activity. Lipase activity was determined by measuring the rate of release of oleic acid from triolein. Brie¯y, a suspension of triolein (80 mg), phosphatidylcholine (10 mg) and taurocholic acid (5 mg) in 9 ml of 0.1 M N -tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid (TES) buffer (pH 7.0) containing 0.1 M NaCl was sonicated for 5 min. This sonicated substrate suspension (100 ml) was incubated with 50 ml (10 units) of pancreatic lipase and 100 ml of various concentrations of chondroitin sulfate solution for 30 min at 37 C in a ®nal volume of 250 ml. The amount of released oleic acid was determined by the method of Zapf et al 9 with a slight modi®cation. 10 The incubation mixture was added to 3 ml aliquots of a 1 : 1 (vav) mixture of chloroform and n-heptane containing 2% (vav) methanol and extracted by shaking the tubes horizontally for 10 min in a shaker. The mixture was centrifuged at 2000 g for 10 min, and the upper aqueous phase was removed by suction. Copper reagent (1 ml) was then added to the lower organic phase. The tube was shaken for 10 min, the mixture was centrifuged at 2000 g for 10 min, and 0.5 ml of the upper organic phase, which contained copper salts of the extracted free fatty acids, was treated with 0.5 ml of 0.1% (wav) bathocuproine in chloroform containing 0.05% (wav) 3(2)-t-Butyl-4-hydroxyanisole. The absorbance was then measured at 480 nm. In addition, pancreatic lipase activity was determined using gum arabic as emulsi®er: 45 mg of gum arabic instead of phophatidylcholine was used and the enzyme activity was assayed as described above. Lipase activity was expressed as mmoles of oleic acid released per ml of reaction mixture per hour.
Lipid absorption by brush border membrane vesicles. Brush border membrane vesicles were prepared from the jejunum portion of the rat small intestine according to the method of Kessler et al. 11 Donor vesicles composed of egg phosphatidylcholinea 2-monooleoylglycerol (93 : 7 mol ratio) and a trace of 3 H-2-monooleolylglycerol were made by sonicating 1.0 ml of the mixed lipid dispersion in 10 mM Hepes ± Tris buffer (pH 7.5) containing 100 mM mannitol (buffer A) for 5 min at 4 C. The assay mixture for investigating lipid absorption consisted of 0.24 ml of buffer A containing 5.9 nmol of 2-monooleoylglycerol (34,000 dpm) and the brush border membrane vesicles (48 mg of protein). Incubation was carried out for 30 min at 20 C. After incubation, 0.1 ml of the incubation medium was diluted with 1 ml of ice-cold buffer A, and this solution was immediately ®ltered through 0.45 mm cellulose nitrate ®lters and washed four times with 1 ml of ice-cold buffer A. The ®lters were then dissolved in ACS II according to the supplier's instructions (Amersham Japan, Tokyo, Japan) and their radioactivity was measured. For the palmitic acid absorption test, donor vesicles composed of phosphatidylcholineapalmitic acid (93 : 7, molar ratio) and a trace of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C] palmitic acid were made by sonicating these substances in buffer A. The donor vesicles (29 nmol palmitic acid; 160,000 dpm) were incubated with the brush border membrane vesicles (48 mg of protein) for 30 min at 20 C, and then the donor vesicles were separated from the brush border membrane by ®ltration as described above.
Estimation of plasma triacylglycerol levels after oral administration of lipid emulsion in rats. Male Wistar King strain rats (220 g body weight) were fed laboratory chow diet containing 10% chondroitin sulfate for 10 days ad libitum, and then the rats were fasted overnight and then orally administered 1 ml of lipid emulsion consisting of corn oil (3 ml), cholic acid (40 mg) and cholesteryloleate (1 g) plus saline (1 ml) or the lipid emulsion (1 ml) plus chondroitin sulfate solution (20 mgaml). The blood sample Anti-obesity activity of chondroitin sulfate L-K Han et al was taken from the tail vein 0, 1, 2, 4, 6 and 8 h after administration of the lipid emulsion with or without chondroitin sulfate using heparinized capillary tube, and centrifuged at 8000 rpm for 5 min by model KH-120M (Kubota, Tokyo, Japan) to obtain the plasma. The plasma triacylgylcerol was determined using a Triglyceride E-Test Wako Kit.
Estimation of body weights, and plasma and liver lipids in mice fed a high-fat diet. Female ICR mice (3 weeks old) were divided into ®ve groups, with each group matched for body weight, after 1 week of feeding. The control mice (n 10) continued to be fed laboratory pellet chow ad libitum. The basic composition of the experimental diet was as follows (wt%): beef tallow 40%, corn starch 10%, sugar 9%, vitamin mixture 1% and mineral mixture 4%. The composition of the diet for each experimental group was as follows: high-fat group (n 15), casein 36% and basic components; chondroitin sulfate plus highfat diet group (each n 12), different amounts of casein (23%, 29% and 33%) and chondroitin sulfate (13%, 7% and 3%). We reported previously that the variation of casein content in the high-fat diet from 22% to 36% did not affect both body weight or parametrial adipose tissue weight. That is, 22 ± 36% casein content of the high-fat diet caused similar degrees of obesity. 6, 7 Based on these facts, we added chondroitin sulfate to the high-fat diet instead of casein. To avoid auto-oxidation of their fat contents, the feeds were stored at 7 30 C and freshly prepared each day. Each mouse was weighed once a week and the weight was recorded.
The total amount of food intake by each mouse was recorded at least three times a week. The energy intake of control group (per week per mouse; laboratory pellet chow, Oriental Yeast Co. Ltd) was food intake (g)Â3.58 kcalagÂ4.184 kJakcal. Andermann and Dietz 12 reported that the absorption of chondroitin sulfate was not observed in rabbits after oral administration. Based on this result, the amount of chondroitin sulfate intake was not entered in the energy intake calculations in the present experiment. Therefore, the model can be written as: energy intake (kJaweekamouse) mÂ(9Âa% 4Âb% 4Âc% 4 Âd %)Â4.184, where m is the value of the amount of food intake, and a, b, c and d are percentages of beef tallow, corn starch, sugar and casein, respectively.
After 8 weeks of feeding on the indicated experimental diet, the blood of each mouse was taken by venous puncture under anesthesia with diethyl ether. The plasma was prepared and frozen at 7 80 C. Plasma free fatty acid, triacylglycerol and total cholesterol was determined using NEFA C Test Wako, Triglyceride E-Test Wako and Total Cholesterol ETest Wako Kits, respectively. The liver and parametrial adipose tissue were quickly removed and weighed. The liver tissues were stored at 7 80 C. The adipose tissue shreds, each 100 mg in weight, were immediately plunged into a plastic tube containing 1.5 ml of 2% osmium acid in 0.05 M collidine ± HCl buffer at pH 7.4, and tissues were ®xed at 37 C for 72 h. After ®xation, the contents of the plastic container were thoroughly washed through a nylon screen (250 mm) with distilled water. The ®ltrate contained most of the ®xed free cells, but ®brous tissue and some intact shreds of ®xed adipose tissue remained on the ®lter. The tissue shreds were gently rubbed by hand on the ®lter while the washing was continued. This procedure completely separated the tissue into free cells, and produced total recovery of cells in the ®ltrate. These cells were then collected and washed with distilled water by using a ®ner screen (25 mm). The diameter of adipose cell suspensions was determined with osmium tetroxide-®xed cells by scanning electron micrography using a Hitachi H-500 scanning electron microscope (Hitachi Ltd., Hitachinaka, Japan).
The liver triacylglycerol and total cholesterol contents were measured as follows: a portion (0.5 g) of the liver tissue was homogenized in Krebs Ringer phosphate buffer (pH 7.4, 4.5 ml), the homogenate (0.2 ml) was extracted with chloroform-methanol (2 : 1, vav, 4 ml), and the extract was concentrated under a nitrogen stream. The residue was analyzed using Triglyceride E-Test and Total Cholesterol ETest Wako Kits. The coef®cients of variation of the assay system in the present study are 1 ± 3%.
Statistical analysis
The results are expressed as meansAE standard errors (s.e.). Statistical analysis was performed using Student's t-test, Fisher's Protected LSD test and Scheffe's test to determine signi®cance using Super ANOVA software (Abacus Concepts, Berkeley, CA).
Results
Effects of chondroitin sulfate on pancreatic lipase activity (in vitro)
As shown in Figure 1 , chondroitin sulfate inhibited the pancreatic lipase activity dose-dependently at the concentrations of 1 ± 20 mgaml in the assay system using triolein emulsi®ed with phosphatidylcholine; at 10 mgaml, it inhibited trioein hydrolysis about 60%. On the other hand, when triolein was emulsi®ed with gum arabic instead of phosphatidylcholine, chondroitin sulfate only slightly inhibited its hydrolysis at concentrations of over 10 mgaml; at 10 mgaml, it inhibited about 20%.
Effects of chondroitin sulfate on palmitic acid and 2-monooleoylglycerol uptake into brush border membrane vesicles of rat small intestine (in vitro)
As shown in Figure 2 , chondroitin sulfate inhibited the incorporation of palmitic acid into brush border membrane vesicles dose-dependently at concentrations of 1 ± 10 mgaml; at 10 mgaml, it inhibited Anti-obesity activity of chondroitin sulfate L-K Han et al palmitic acid incorporation about 80%. However, it did not affect the incorporation of 2-monooleoylglycerol (data not shown).
Effects of chondroitin sulfate on plasma triacylglycerol levels after oral administration of lipid emulsion in rats Figure 3 shows the time course of the plasma triacylglycerol concentrations when lipid emulsion with or without chondroitin sulfate was administered orally to rats. Two hours after chondroitin sulfate administration, the plasma triacylglycerol concentration decreased signi®cantly compared with control. No elevation of plasma total cholesterol or free fatty acid level was caused by oral administration of the lipid emulsion (data not shown).
Effects of chondroitin sulfate on food consumption, and body, parametrial adipose tissue and liver weights in mice fed a high-fat diet for 8 weeks
Since chondroitin sulfate could not be absorbed by oral administration, 12 the amount of chondroitin sulfate intake was not entered in the energy intake calculations. The mean food consumption per week per mouse at 4 ± 8 weeks was signi®cantly (P`0.05) different between the control group and high-fat-diet groups, being 533.9AE 19.1 kJaweekamouse in the control group and 1026.0 AE 38.0 kJaweekamouse in the high-fat diet group, but not signi®cantly different among the high-fat plus chondroitin sulfate (3%, 7% or 13%) groups, being 1026.0AE 38.0 kJaweekamouse (high-fat diet group), 1074.0AE 19.7 kJaweekamouse (high-fat diet plus 3% chondroitin sulfate group), 990.5 AE 16.0 kJaweekamouse (high-fat diet plus 7% chondroitin sulfate group) and 1017.0AE 20.3 kJa weekamouse (high-fat diet plus 13% chondroitin sulfate group), respectively.
Figures 4 and 5 show the changes in body weights, liver and parametrial adipose tissue weights of the groups during the experiment. Feeding a high-fat diet for 8 weeks caused signi®cant increases in body weight at 2 ± 8 weeks, and in the liver and parametrial adipose tissue weights, as compared to the control diet Anti-obesity activity of chondroitin sulfate L-K Han et al group (laboratory pellet chow). The body weight at 3 ± 8 weeks and parametrial adipose tissue and liver weights were signi®cantly reduced by feeding a highfat diet containing 7% or 13% chondroitin sulfate as compared to feeding a high-fat diet alone. Feeding a high-fat diet containing 3% chondroitin sulfate slightly, but not signi®cantly reduced in the body weight. However, feeding a high-fat diet containing 3% chondroitin sulfate signi®cantly reduced parametrial adipose tissue weight.
Effects of chondroitin sulfate on the diameter of fat cells in mice fed a high-fat diet for 8 weeks
As shown in Figure 6 , the diameter of fat cells was signi®cantly greater in the high-fat diet group than in the control group, and chondroitin sulfate completely prevented the high-fat diet induced increase in cell diameter.
Effects of chondroitin sulfate on plasma and liver lipids in mice fed a high-fat diet for 8 weeks
As shown in Tables 1 and 2 , feeding a high-fat diet caused hyperlipidemia with elevations of plasma triacylglycerol (2.3-fold), total cholesterol (1.4-fold) and free fatty acid (1.5-fold), and caused fatty liver with accumulation of triacylglycerol (5.8-fold) and total cholesterol (1.4-fold). Plasma triacylglycerol and total cholesterol were signi®cantly reduced by feeding a high-fat diet containing 3%, 7% or 13% chondroitin sulfate as compared to feeding a high-fat diet alone: 68%, 70% or 62% for triacyglycerol and 80%, 79% or 70% for total cholesterol at 3%, 7% or 13% chondroitin sulfate diet, respectively (Table 1) . Plasma free fatty acid was also signi®cantly reduced by treatment with 13% chondroitin sulfate as compared to feeding a high-fat diet alone (about 84%). Chondroitin sulfate also prevented the accumulation of hepatic triacylglycerol and total cholesterol caused by a high-fat diet: 76%, 58% or 55% for triacylglycerol and 75%, 71% Anti-obesity activity of chondroitin sulfate L-K Han et al or 65% for total cholesterol, respectively, as compared to feeding a high-fat diet alone (Table 2 ).
Discussion
It is well known that dietary fat is not directly absorbed from the intestine unless it has been subjected to the action of pancreatic lipase. 13 The two main products formed by the hydrolysis of pancreatic lipase are fatty acids and 2-monoacylglycerols. 14 These lipolytic products are mixed with bile salts, dispersed as micelles, and carried in this form to the site of fat absorption. Lipid absorption takes place in the apical part of the plasma membrane of epithelial cells or enterocytes lining the gut. Previously, we found that basic protein such as protamine, histones and purothionine inhibited the hydrolysis of triolein emulsi®ed with phosphatidylcholine in an assay system for the pancreatic lipase activity. 5 Furthermore, we reported that the glucosamine polymer chitosan, which had a positive charge, inhibited the hydrolysis of triolein emulsi®ed with phosphatidylcholine as well as the basic protein protamine, but not the hydrolysis of triolein emulsi®ed with gum arabic and Triton X-100. 6 Based on these experimental results, we found that chitosan prevented the increase in vivo of body and parametrial adipose tissue weights induced by a high-fat diet containing 40% beef tallow, through inhibition of the intestinal absorption of dietary fat. 6 In a previous report, 1 we showed that chondroitin sulfate inhibited glucose uptake into brush border membrane vesicles prepared from rat small intestines. In the present study, we ®rst attempted to examine the effects of chondroitin sulfate on pancreatic lipase activity and lipid incorporation into brush border membrane vesicles. Chondroitin sulfate inhibited the hydrolysis of triolein emulsi®ed with phosphatidylcholine in an assay system for pancreatic lipase activity. The inhibitory effects of chondroitin sulfate on the hydrolysis of triolein emulsi®ed with phosphatidylcholine by pancreatic lipase were stronger than Anti-obesity activity of chondroitin sulfate L-K Han et al those on the hydrolysis of triolein emulsi®ed with gum arabic. These results suggest that the inhibitory effects of chondroitin sulfate (an acidic polymer) on pancreatic lipase activity may be mediated by the interaction between substrate and enzyme mediated through phosphatidylcholine, as are the effects of chitosan (a basic polymer) and protamine (a basic protein). Chitosan and protamine have overall positive charges in their structure, but chondroitin sulfate has a net negative charge. Therefore, further studies are needed to clarify whether chondroitin sulfate binds to the substrate site or enzyme site. In addition, chondroitin sulfate inhibited the incorporation of fatty acid into brush border membrane vesicles, but not that of 2-momoacylglycerol. Previously, we reported that lactosucrose (4 G -b-D-galactosylsucrose) exerts anti-obesity action through inhibiting 2-monoacylglycerol incorporation into brush border membranes, without affecting the incorporation of fatty acid. 15 The inhibitory mechanism of chondroitin sulfate on small intestinal absorption of lipids (fatty acid and 2-monoacylglycerol) formed by pancreatic lipase also needs to be clari®ed. Based on these in vitro experiments, we con®rmed that chondroitin sulfate reduced the elevation of plasma triacylglycerol after oral administration of a lipid emulsion containing corn oil in rats. Furthermore chondroitin sulfate enhanced fat excretion into feces of mice fed a high-fat diets for 3 days (data not shown). Thus, it seems likely that the reduction of plasma triacylglycerol levels and the enhancement of fat excretion into feces by chondroitin sulfate may be mediated through the inhibition of both intestinal absorption of the free fatty acid and pancreatic lipase activity.
Moreover, in the long-term (8 weeks) experiments, it was con®rmed that chondroitin sulfate signi®cantly reduced both body weight and parametrial adipose tissue weight at doses of 30 (3%), 70 (7%) and 130 (13%) gakg food, whereas no signi®cant differences in the energy consumed were found among the experimental groups (except the laboratory chow diet control group). The differences in the rate of increase in weight of the parametrial adipose tissue seemed to be due to changes in both size and number of fat cells. This result indicates that chondroitin sulfate prevents the high-fat-diet-induced increase of body weight by affecting food absorption. Furthermore, chondroitin sulfate was found to prevent the fatty liver induced by the high fat diet and to reduce serum triacylglycerol, total cholesterol and free fatty acid, which were elevated in the high-fat-diet fed mice. There are reports that both adipocyte size and number are increased in animals with obesity caused by a highfat diet. 16, 17 We reported that basal lipolysis in the absence of lipolytic hormones was usually increased in enlarged adipocytes in aged andaor obese animals. 18 The elevation of basal lipolysis causes an increase in plasma free fatty acid, which are then converted to lipids in the liver and secreted into the blood as very low density lipoprotein. Therefore, the reduction of obesity by chondroitin sulfate may cause a reduction of basal lipolysis in adipocytes of the obese mice, followed by a decrease in serum free fatty acid, triacylglycerol, total cholesterol and liver lipids.
From the present study, it seems likely that chondroitin sulfate prevents the high-fat-diet-induced obesity through the inhibition of intestinal absorption of dietary fat, and consequently causes a prevention of the fatty liver and hyperlipidemia in obese mice Anti-obesity activity of chondroitin sulfate L-K Han et al through a decrease in the basal lipolysis in adipocytes of the obese mice.
Conclusion
Chondroitin sulfate is shown to inhibit pancreatic lipase in vitro, and fat absorption in vitro in jejumal brush border membrane vesicles and in vivo in mouse. These data suggest that chondroitin sulfate is strong candidate for an agent that inhibit lipid absorption.
